Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cephalon's Provigil Produces Eye-Opening 40% Off-label Use - CEO Baldino

Executive Summary

About 40% of scripts for Cephalon's narcolepsy therapy Provigil (modafinil) are being written for off-label indications, Cephalon CEO Frank Baldino said at a Burns McClellan/Petkevich & Partners analyst meeting in London Oct. 6.

You may also be interested in...



Cephalon Marketing Under Investigation By Philadelphia U.S. Attorney

The Philadelphia U.S. Attorney's investigation into Cephalon's marketing practices covers the entire commercial life of Provigil

Cephalon Marketing Under Investigation By Philadelphia U.S. Attorney

The Philadelphia U.S. Attorney's investigation into Cephalon's marketing practices covers the entire commercial life of Provigil

Provigil Revamped Marketing Campaign To Launch After FDA Cites Promotions

Cephalon plans to proceed with a new marketing program for Provigil (modafinil) in February after receiving a letter from FDA objecting to many of its current promotional materials for the narcolepsy drug

Related Content

UsernamePublicRestriction

Register

PS034947

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel